Sign In
Buy MRVI
$4.84
+0.0100 (+0.207%)
At Close: Jun 03, 2026
Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – MRVI
06:00pm, Tuesday, 08'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 8, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the fede
NEW YORK, NY / ACCESS Newswire / April 8, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the fede
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2025 in Maravai LifeSciences Lawsuit - MRVI
04:00pm, Tuesday, 08'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 8, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the fede
NEW YORK CITY, NY / ACCESS Newswire / April 8, 2025 / WHY: New York, N.Y., April 8, 2025.
NEW YORK, NY / ACCESS Newswire / April 8, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the fede
SAN FRANCISCO, CA / ACCESS Newswire / April 8, 2025 / On Mar. 19, 2025, the price of Maravai LifeSciences (NASDAQ:MRVI) shares fell almost 6% after the company warned investors against relying on prev
NEW YORK, NY / ACCESS Newswire / April 8, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the fede
Class Action Filed Against Maravai LifeSciences Holdings, Inc. (MRVI) Seeking Recovery for Investors - Contact Levi & Korsinsky
10:25am, Tuesday, 08'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 8, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the fede
NEW YORK , April 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI).
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
09:54am, Tuesday, 08'th Apr 2025
LOS ANGELES , April 8, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc
NEW YORK, NY / ACCESS Newswire / April 8, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the fede
NEW YORK CITY, NY / ACCESS Newswire / April 8, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Marava
NEW YORK , April 8, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action sec
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2025 in Maravai LifeSciences Lawsuit - MRVI
05:15pm, Monday, 07'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the fede
SAN FRANCISCO, April 07, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Ready Capital Corporation (NYSE: RC) after the company reported dismal financial results and
